|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Coxsackievirus IgM ELISA | Bevacizumab (Avastin®) ELISA | Bordetella pertussis IgG ELISA | Insulin-like Growth Factor-Binding Protein-3 (IGFBP-3) ELISA | Vitamin D3, 1-25-OH RIA CT Assay |
| Catalog Number | IB05041 | TM09010 | IB79850 | E03A | KIR1929 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of human IgM antibodies directed against Coxsackie viruses in serum or plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Bevacizumab (Avastin®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The Bordetella pertussis IgG ELISA is intended for the determination of IgG class antibodies against Bordetella pertussis in human serum or plasma (citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of IGFBP-3 in human serum, plasma (heparin), or cerebrospinal fluid. For research use only, not for use in diagnostic procedures. | Radioimmunoassay (RIA) for the determination of human 1,25(OH)2-Vitamin D (1,25(OH)2-Vit.D) in serum and plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Coxsackievirus IgM | Bevacizumab (Avastin®) | Secretoneurin (Human) | Complement System Screen | Lysozyme |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Serum and plasma. | Serum, Blood Plasma | Serum | Serum, Stool, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 0 / 6 to 200 ng/mL | A cut-off control is used for the interpretation of results. | 0.4 to 30.0 ng/mL | 4.7 to 411 pg/mL |
| Sensitivity | > 90% | 2 ng/mL | 7.6 pmol/L | Inquire | Inquire |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | 1 hour, 45 min. total incubation time. | 1 hr 45 mins (incubation) | 2 hrs 30 mins (incubation) | Overnight + 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |